Report topline results from the pivotal B-SIMPLE4 Phase 3 study of SB206 in molluscum
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Topline Results Targeted Before the End of Q2 2021”
What we found
Evidence strength A What the grades mean
Later 8-K filings state Novan reported positive B-SIMPLE4 topline results in June 2021, before the end-of-Q2 2021 deadline.
-
A Novan, Inc. 8-K filed 2021-08-12
“In June 2021, the Company reported positive topline results, including statistical significance for the primary endpoint with a p-value of less than 0.0001.” ✓ confirmed on the page
-
A Novan, Inc. 8-K filed 2021-09-09
“In June 2021, Novan reported statistically significant positive topline results for the primary endpoint (p-value <0.0001)” ✓ confirmed on the page
-
A Novan, Inc. 10-Q filed 2022-05-16
“the trading price of our common shares increased significantly in June 2021, which we believe was attributable to general market conditions and recognition of our announcement of top-line results of our B-SIMPLE4 study” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout late
- Indicative materiality
- High rules
- Action
- Report
- Deliverable
- B-SIMPLE4 Phase 3 topline results for SB206
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Novan, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C467154-024559 · Corrections policy